atenolol has been researched along with carteolol in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (25.00) | 18.7374 |
| 1990's | 4 (25.00) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 1 (6.25) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Carrupt, PA; el Tayar, N; Testa, B; Van de Waterbeemd, H | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Asayama, K; Dobashi, K; Hayashibe, H; Kato, K | 1 |
| Kohno, M; Kurihara, N; Murakawa, K; Takeda, T; Yasunari, K; Yokokawa, K | 1 |
| Devynck, MA; Filitti, V; Le Quan Sang, KH; Levenson, J; Pithois-Merli, I; Simon, A | 1 |
| Filitti, V; Levenson, J; Merli, IP; Simon, A | 1 |
| Chiba, S; Kobayashi, M; Shimotori, M | 1 |
| Hatori, Y; Horii, M; Nakamura, Y; Nemoto, E; Otsuka, K; Sakai, T; Tsukiyama, H; Yamamoto, Y; Yamato, T; Yoshii, Y | 1 |
| Hagihara, T; Kishi, Y; Matsumoto, G; Matsuo, H; Naka, K; Nanjo, K; Ohoshi, T; Sanke, T; Sasaki, H; Sowa, R | 1 |
| Chidlow, G; Melena, J; Osborne, NN | 1 |
| Clark, JI; Martin, RW; Vaezy, S; Zderic, V | 1 |
| Chiba, I; Hiramori, K; Kobayashi, N; Saito, M; Segawa, I; Taniguchi, Y; Ueshima, K | 1 |
| Carlo, MJ; Patrick, AL | 1 |
1 review(s) available for atenolol and carteolol
| Article | Year |
|---|---|
Modeling of beta-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Models, Molecular; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1988 |
3 trial(s) available for atenolol and carteolol
| Article | Year |
|---|---|
Acute effects of alpha- and beta-adrenoceptor blockade on plasma atrial natriuretic peptides during exercise in elderly patients with mild hypertension.
Topics: Aged; Atenolol; Atrial Natriuretic Factor; Carteolol; Exercise; Female; Humans; Hypertension; Male; Middle Aged; Multivariate Analysis; Prazosin; Ventricular Function, Left | 1991 |
Dynamic association between artery shear flow condition and platelet cytosolic free Ca2+ concentration in human hypertension.
Topics: Arteries; Atenolol; Blood Platelets; Calcium; Carteolol; Cytosol; Double-Blind Method; Female; Hemodynamics; Humans; Hypertension; Male; Rheology; Stress, Mechanical | 1990 |
Comparative long-term vasoactive effects of atenolol and carteolol on the properties of the small and large arteries of the upper extremities in human essential hypertension.
Topics: Adult; Arteries; Atenolol; Blood Flow Velocity; Blood Pressure; Brachial Artery; Carteolol; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Propanolamines; Randomized Controlled Trials as Topic; Ultrasonics; Vascular Resistance | 1989 |
12 other study(ies) available for atenolol and carteolol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Differential effects of 3 beta blockers on lipid peroxidation in hyperthyroid muscle.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Body Weight; Carteolol; Hyperthyroidism; Lipid Peroxidation; Male; Mitochondria, Muscle; Muscles; Organ Size; Propanolamines; Rats; Rats, Inbred Strains; Thiobarbiturates | 1990 |
Comparative study of five beta-adrenoceptor blocking agents on sinoatrial conduction time in isolated blood-perfused canine atria.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Carteolol; Dogs; In Vitro Techniques; Oxprenolol; Propranolol; Sinoatrial Node; Sotalol | 1985 |
Possible significance of the pharmacological differentiation of beta-blocking agents in hemodynamic effects in essential hypertension.
Topics: Acebutolol; Adrenergic beta-Antagonists; Atenolol; Carteolol; Hemodynamics; Humans; Hypertension; Metoprolol; Oxprenolol; Propranolol | 1983 |
Nicardipine may impair glucose metabolism in hypertensive diabetic patients.
Topics: Adult; Aged; Atenolol; Carteolol; Diabetes Mellitus, Type 2; Diltiazem; Enalapril; Female; Glucose; Glycated Hemoglobin; Humans; Hypertension; Male; Metoprolol; Middle Aged; Nicardipine; Propanolamines | 1994 |
Betaxolol, a beta(1)-adrenoceptor antagonist, reduces Na(+) influx into cortical synaptosomes by direct interaction with Na(+) channels: comparison with other beta-adrenoceptor antagonists.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Atenolol; Batrachotoxins; Betaxolol; Binding, Competitive; Carteolol; Cerebral Cortex; Dose-Response Relationship, Drug; Kinetics; Levobunolol; Membranes; Propranolol; Rats; Rats, Wistar; Saxitoxin; Sodium; Sodium Channels; Sodium Radioisotopes; Synaptosomes; Timolol; Tritium | 2000 |
Ocular drug delivery using 20-kHz ultrasound.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Betaxolol; Carteolol; Cornea; Drug Delivery Systems; Epithelium; Models, Animal; Permeability; Rabbits; Timolol; Ultrasonics | 2002 |
A new method using pulmonary gas-exchange kinetics to evaluate efficacy of beta-blocking agents in patients with dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Blood Pressure; Cardiomyopathy, Dilated; Carteolol; Dose-Response Relationship, Drug; Drug Therapy, Combination; Echocardiography; Exercise Test; Female; Heart Rate; Humans; Male; Metoprolol; Middle Aged; Oxygen; Pulmonary Gas Exchange; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2003 |
Further exploration of the collision-induced dissociation of select beta blockers: Acebutolol, atenolol, bisoprolol, carteolol, and labetalol.
Topics: Acebutolol; Atenolol; Bisoprolol; Carteolol; Chromatography, Liquid; Labetalol; Tandem Mass Spectrometry | 2023 |